#Surgimap

[orthotv]

🌟 Get ready for NMOACON 2024 🌟

🦴 Spine Workshop - AI and Technology in Spine Surgery

📅 Date: 20th September 2024

⏰ Time: 02:00 PM - 05:00 PM

📍 Venue: Apollo Hospital, Belapur

📝 Click here to register!: https://bit.ly/OrthoTV-NMOACON2024

💸 Workshop Registration Charges: Rs. 2,000 + Rs. 360 (GST) = Rs. 2,360/- (Note: Workshop registration is independent of the conference registration.)

📜 2 MMC Points Accredited

Program Highlights:

Session 1: Using Surgimap and Spine Score App

Measuring various parameters on Surgimap

Performing osteotomies to improve sagittal alignment Session 2: Navigation in Spine Surgery

Overview of navigated spine surgery techniques

Demonstration on a model using the Navigation system Session 3: Hands-On Workshop: Burring Techniques on Midas Rex & Bone Scalpel

Hands-on exercises using animal bone models

Table Faculty: Dr. Subhash Diware, Dr. Pravin Padalkar, Dr. Sumeet Sonawane, Dr. Rahul Prakash

💡 Convenor: Dr. Agnivesh Tikoo

💡 Co-convenor: Dr. Arvind Vatkar

👨‍⚕ Dr Sachin Kale Organising Chairman

👨‍⚕ Dr Pramod Bhor Organising Secretary

👨‍⚕ Dr Sanjay Dhar Scientific Committee Chairman

▶ Media partner: OrthoTV Global

🔗 Join OrthoTV: https://linktr.ee/OrthoTV

[rishabhcmi]

MOTION PRESERVATION DEVICES MARKET ANALYSIS (2020-2027)

Motion preservation devices are used to treat spinal disorders such as spinal stenosis, which is very common and occur in both men and women. These devices are also used to restore and maintain the alignment of spine as per normal. Motion preservation devices follow usually a minimally invasive procedure, which preserves or re-generate normal motion of spine. This disorder most commonly occurs in geriatric population, as ageing causes some structural changes in human spine such as thickening of tissue’s band (which supports spine) and enlargement of bones and joints.

Global Motion Preservation Devices Market Drivers

Recent trends such as merger & acquisitions are expected to support the global motion preservation devices market growth. For instance, in March 2019, RTI Surgical Holdings acquired Paradigm Spine LLC, a provider of the product ‘Coflex’ (interlinear stabilization device). Moreover, DePuy-Synthes acquired Emerging Implant Technologies GmbH (EIT) in 2018, for 3D-printed titanium implants, which are used in treatment of spinal disorders. Furthermore, CTL Medical acquired spine business of Amedica Corporation and became CTL Amedica in 2018. Orthofix also acquired Spinal Kinetics in 2018, for ‘M6’ artificial discs to strengthen their product portfolio. Moreover, companies such as Globus Medical have product line for motion preservation treatment such as Acadia, Secure-C, and Triumph. Acadia is a motion sparing facet replacement technology, Secure-C is a cervical artificial disc, and Triumph is a lumbar disc. Mobi-C cervical disc of Zimmer Biomet Holdings, Inc. is the first cervical disc replacement approved by U.S. Food Drug Administration (FDA) in 2013 for both one and two-level indications.

Companies such as Centinel Spine, LLC are planning to launch patient education and support programs in July 2019, for creating awareness among people. In 2015, Arthrosurface, Inc. launched the motion preserving WristMotion hemiarthroplasty implant. It is designed to preserve more bone than other implants, therefore, it is widely accepted treatment mode for motion preservation. In 2018, Globus Medical, Inc. acquired Nemaris Inc., a provider of product Surgimap a ‘surgical planning software’, which will help healthcare professionals to identify possible surgical outcomes and share medical imaging to improve procedural workflow and patient care. Such initiatives can help in providing better treatment to patients and will drive the global motion preservation devices market growth.

Global Motion Preservation Devices Market Restraints

Major factors restraining global motion preservation devices market growth are high cost of treatment, as these devices are very costly and cost of surgery is also high. It is not affordable to majority of population in emerging economies. Major limitation in motion preservation treatment includes fusion of one or more segments, which leads to changes in biomechanics of spine affecting the lumbar spine mobility. This affects patient’s ability to adjust the spine position while performing routine activities such as switching from the sitting to standing position or vice versa. These factors are expected to restrain global motion preservation devices market growth up to certain extent.

Global Motion Preservation Devices Market Regional Analysis

North America region is expected to hold dominant position in the global motion preservation devices market, owing to increasing number of motion preservation device approvals in the region for treatment of various spinal injuries. According to National Spinal Cord Injury Statistical Centre (NSCISC), in U.S there is an increase in prevalence of spinal injuries (17,500 Spinal Injury cases each year), which is expected to boost the global motion preservation devices market growth over the forecast period. In Europe, leading manufacturers such as SpineVision offers FlexPLUS, a motion-preservation device. Major players such as Medtronic and Zimmer Biomet offer several products for motion preservation in this region such as artificial discs and bone sparing technology respectively. According to European Health Interview Survey (EHIS), in 2014, around 59% of adults reported in Poland are suffering from health problems or chronic disease related to spine. Their major complaint was about lower back pain. According to same source 28.4% of females and 21.2% of males aged 15 years and above were followed by neck pain and 19% of women and 12.9% of men suffered from middle back pain in Poland. Such incidences may result in complications, which can lead to necessity of surgical intervention for such conditions, which is expected to boost global motion preservation devices market growth.

Global Motion Preservation Devices Market Key Players

Some of the key players operating in the global motion preservation devices market include B. Braun Melsungen AG, Aurora Spine Corporation, Globus Medical, Inc., HPI Implants, RTI Surgical, Zimmer Biomet Holdings, Inc., and Orthofix Spinal Implants Inc.

Request the sample copy of here:

https://www.coherentmarketinsights.com/insight/request-sample/2971

Download the PDF Brochure here:

https://www.coherentmarketinsights.com/insight/request-pdf/2971

Global Motion Preservation Devices Market Taxonomy

By Product Type

Prostheses Devices

Annulus Repair Devices

Fusion Devices

Non-fusion Devices

Thoracic Fusion

Cervical Fusion

Lumbar Fusion

Artificial Discs

Dynamic Stabilization Devices

Cervical Discs

Lumbar Discs

Facet Replacement Products

Pedicle Screw-Based Systems

Interspinous Process Spacers

By End User

Clinics

Hospitals

Ambulatory Surgical Centers

Orthopedic Clinics

Others

By Region

North America

Latin America

Europe

Asia Pacific

Middle East

Africa

Buy now the market research report here:

https://www.coherentmarketinsights.com/insight/buy-now/2971

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions.

What we provide:

Customized Market Research Services

Industry Analysis Services

Business Consulting Services

Market Intelligence Services

Long term Engagement Model

Country Specific Analysis

Explore CMI Services here

Contact Us:

Mr. Shah

Coherent Market Insights Pvt. Ltd.

Address: 1001 4th ave, #3200 Seattle, WA 98154, U.S.

Phone: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Source:

https://www.coherentmarketinsights.com/ongoing-insight/motion-preservation-devices-market-2971

[monchiropracteur]

A critical thoracic kyphosis is required to prevent sagittal plane deterioration in selective thoracic fusions in Lenke I and II AIS

http://monchiropracteur.com/ monchiropracteur.com Abstract Purpose Thoracic hypokyphosis following AIS correction may be associated with reduced lumbar lordosis with potential adverse effects on the global sagittal balance. In the present study, we were interested in how the amount of thoracic kyphosis influences the sagittal profile and balance in selective thoracic (STF) and thoracolumbar fusions. Methods Out of 154 patients, 86 patients had correction of AIS Lenke I or II with a side-loading pedicle screw system and completed a 2-year follow-up. Patient factors such as age, Risser grade, lowest and upper instrumented vertebra, and lumbar modifier were recorded. Coronal Cobb and sagittal parameters were measured using Surgimap. Statistical analysis according to distributions and multiple linear and logistic regressions was performed using STATA for Mac v13. Results In STF, logistic regression against post-operative change in SVA versus thoracic kyphosis allowed calculation of a critical thoracic kyphosis of 23° (ROC AUC 0.65, spec 0.70, sens 0.63), below which deterioration of the sagittal vertical axis is more likely (PPV 71.4%). Patients with hypokyphosis exhibited an increase in the SVA (pre-operative 7.2 ± 37.1 mm vs. 23.1 ± 27.6 mm at 2 years, p = 0.0164), whereas it was maintained from pre-operative to 2 years post-operative if thoracic kyphosis is above 23° (pre-operative 2.5 ± 28.9 mm vs. 5.4 ± 26.9 mm at 2 years, p = 0.579). Conclusion A critical thoracic kyphosis of 23° and more should be aimed for in hypokyphotic patients to potentially avoid post-operative sagittal plane deterioration with mechanical and likely also clinical consequences. Graphic abstract These slides can be retrieved under Electronic Supplementary Material. http://link.springer.com/10.1007/s00586-019-06093-z?utm_source=dlvr.it&utm_medium=tumblr http://monchiropracteur.com/

[randybenedict]

Globus Medical Q3 beats The Street

Globus Medical (NYSE:GMED) today posted third quarter earnings that handily topped expectations from analysts on Wall Street.

The Audubon, Pa.-based company posted profits of $35.2 million, or 35¢ per share, on sales of $169.2 million for the three months ended September 30, for bottom-line growth of 37.6% on sales growth of 11.5% compared with the same period last year.

Adjusted to exclude one-time items, earnings per share were 39¢, ahead of the 32¢ consensus on The Street, where analysts were looking for sales of $167.5 million, which the company topped.

“The third quarter marks the fourth consecutive quarter of double-digit organic growth for Globus Medical, as our U.S. spine business continues to take market share, growing by 7.5%; our international revenue increased by 16.8%; and emerging technologies contributed $6.3 million. During the third quarter, we completed the acquisition of Surgimap, the leading surgical planning software for spine.  The addition of Surgimap will further strengthen Globus Medical’s ExcelsiusGPS platform by streamlining workflow and enabling superior data analytics.  The level of adoption we are seeing by surgeons in accounts with our ExcelsiusGPS robotic system continues to show positive momentum and the pipeline for potential robotic sales is robust,” CEO Dave Demski said in a press release.

Globus Medical lifted its guidance for the full year 2018, expecting to see sales of $705 million and non-GAAP diluted EPS of $1.62, up from earlier guidance of $700 million in sales and non-GAAP EPS of $1.55.

Globus Medical shares rose 1.1% today, closing at $57.47.

In September, Globus Medical said that it t acquired Nemaris and its Surgimap planning software for an undisclosed amount.

The post Globus Medical Q3 beats The Street appeared first on MassDevice.

from MassDevice https://ift.tt/2RLFi6o

[nonviable-hostage]

via robotics - Google News

[randybenedict]

Globus Medical picks up Surgimap for ExcelsiusGPS robot-assisted surgery device

Globus Medical (NYSE:GMED) said yesterday that it acquired Nemaris and its Surgimap planning software for an undisclosed amount.

Globus said it plans to integrate New York City-based the Nemaris tech into its ExcelsiusGPS robot-assisted surgery platform.

“The acquisition of Surgimap bolsters Globus Medical’s efforts to advance the future of computer-assisted surgery with the goal of improving patient outcomes,” CEO Dave Demski said in prepared remarks. “Software-enhanced solutions are critical components of the future of computer-assisted surgery, and Surgimap is the leading surgical planning software technology in the spine market today. We are very excited about the strategic fit of this acquisition, which will allow us to further enhance the capability of our ExcelsiusGPS navigation and robotic system to assist surgeons in planning complex spine procedures and placing screws more accurately and less invasively.”

“The acquisition will enable Globus to combine Surgimap’s best-in-class spine surgery planning technology with the best-in-class robotic and navigation technology of ExcelsiusGPS,” added Nemaris co-founder Dr. Frank Schwab of New York’s Hospital for Special Surgery. “We think the synergies bring enormous benefit to the entire spine community and particularly surgeons who are interested in less invasive robotic and navigation based procedures.”

The post Globus Medical picks up Surgimap for ExcelsiusGPS robot-assisted surgery device appeared first on MassDevice.

from MassDevice https://ift.tt/2p4v2K5